AUDENSIEL HEALTHCARE : revenue, balance sheet and financial ratios

AUDENSIEL HEALTHCARE is a French company founded 10 years ago, specialized in the sector Conseil en systèmes et logiciels informatiques. Based in BOULOGNE-BILLANCOURT (92100), this company of category ETI shows in 2024 a revenue of 8.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - AUDENSIEL HEALTHCARE (SIREN 818919995)
Indicator 2024 2022 2021 2020 2019
Revenue 8 130 887 € 12 434 681 € 4 759 268 € 2 986 584 € 2 934 993 €
Net income 1 669 635 € 1 820 504 € 995 114 € 595 582 € 752 955 €
EBITDA 1 868 542 € 1 959 399 € 1 194 031 € 484 505 € 707 189 €
Net margin 20.5% 14.6% 20.9% 19.9% 25.7%

Revenue and income statement

In 2024, AUDENSIEL HEALTHCARE achieves revenue of 8.1 M€. Over the period 2019-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +22.6%. Significant drop of -35% vs 2022. After deducting consumption (0 €), gross margin stands at 8.1 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 1.9 M€, representing 23.0% of revenue. Positive scissor effect: EBITDA margin improves by +7.2 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 1.7 M€, i.e. 20.5% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

8 130 887 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

8 130 887 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

1 868 542 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

1 873 667 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

1 669 635 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

23.0%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 17%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 45%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.2 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 20.5% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

16.981%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

45.374%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

20.542%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.18

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

40.9%

Solvency indicators evolution
AUDENSIEL HEALTHCARE

Sector positioning

Debt ratio
16.98 2024
2021
2022
2024
Q1: 0.0
Med: 3.93
Q3: 32.58
Average +36 pts over 3 years

In 2024, the debt ratio of AUDENSIEL HEALTHCARE (16.98) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
45.37% 2024
2021
2022
2024
Q1: 7.97%
Med: 34.38%
Q3: 62.44%
Good -15 pts over 3 years

In 2024, the financial autonomy of AUDENSIEL HEALTHCARE (45.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
0.18 years 2024
2021
2022
2024
Q1: 0.0 years
Med: 0.0 years
Q3: 0.5 years
Average +34 pts over 3 years

In 2024, the repayment capacity of AUDENSIEL HEALTHCARE (0.18) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 213.44. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

213.44

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

0.0

Liquidity indicators evolution
AUDENSIEL HEALTHCARE

Sector positioning

Liquidity ratio
213.44 2024
2021
2022
2024
Q1: 141.9
Med: 230.48
Q3: 460.89
Average -6 pts over 3 years

In 2024, the liquidity ratio of AUDENSIEL HEALTHCARE (213.44) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
0.0x 2024
2021
2022
2024
Q1: 0.0x
Med: 0.0x
Q3: 1.04x
Average -26 pts over 3 years

In 2024, the interest coverage of AUDENSIEL HEALTHCARE (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 80 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 82 days. Favorable situation: supplier credit is longer than customer credit by 2 days. Overall, WCR represents 83 days of revenue, i.e. 1.9 M€ to permanently finance. Over 2019-2024, WCR increased by +128%, requiring additional financing.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

1 874 739 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

80 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

82 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

83 j

WCR and payment terms evolution
AUDENSIEL HEALTHCARE

Positioning of AUDENSIEL HEALTHCARE in its sector

Comparison with sector Conseil en systèmes et logiciels informatiques

Valuation estimate

Based on 215 transactions of similar company sales (all years), the value of AUDENSIEL HEALTHCARE is estimated at 1 796 616 € (range 767 531€ - 6 193 728€). With an EBITDA of 1 868 542€, the sector multiple of 1.0x is applied. The price/revenue ratio is 0.16x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
215 transactions
767k€ 1796k€ 6193k€
1 796 616 € Range: 767 531€ - 6 193 728€
NAF 5 all-time

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
1 868 542 € × 1.0x
Estimation 1 824 910 €
689 275€ - 8 064 737€
Revenue Multiple 30%
8 130 887 € × 0.16x
Estimation 1 305 118 €
700 066€ - 2 384 000€
Net Income Multiple 20%
1 669 635 € × 1.5x
Estimation 2 463 133 €
1 064 373€ - 7 230 798€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Conseil en systèmes et logiciels informatiques)

Compare AUDENSIEL HEALTHCARE with other companies in the same sector:

Voir toutes les statistiques du secteur Conseil en systèmes et logiciels informatiques

Frequently asked questions about AUDENSIEL HEALTHCARE

What is the revenue of AUDENSIEL HEALTHCARE ?

The revenue of AUDENSIEL HEALTHCARE in 2024 is 8.1 M€.

Is AUDENSIEL HEALTHCARE profitable?

Yes, AUDENSIEL HEALTHCARE generated a net profit of 1.7 M€ in 2024.

Where is the headquarters of AUDENSIEL HEALTHCARE ?

The headquarters of AUDENSIEL HEALTHCARE is located in BOULOGNE-BILLANCOURT (92100), in the department Hauts-de-Seine.

Where to find the tax return of AUDENSIEL HEALTHCARE ?

The tax return of AUDENSIEL HEALTHCARE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does AUDENSIEL HEALTHCARE operate?

AUDENSIEL HEALTHCARE operates in the sector Conseil en systèmes et logiciels informatiques (NAF code 62.02A). See the 'Sector positioning' section above to compare the company with its competitors.